Patent ID: 6969507
Filing Date: 2005-11-29
Classification: A61B,A61K

Abstract:
1. A method for assessing the effect of a compound on female sexual arousal disorder or female orgasmic disorder comprising: (a) administering a magnetic resonance imaging contrast agent to a female subject; (b) subjecting the subject to magnetic resonance imaging; (c) measuring an imaging signal characteristic of the contrast agent to establish a baseline; (d) subjecting the female subject to a stimulus designed to cause sexual arousal; (e) monitoring an imaging signal characteristic of the contrast agent to assess the female sexual arousal disorder or female orgasmic disorder after the stimulus; (f) administering a compound hypothesized to produce an effect on the female sexual arousal disorder of female orgasmic disorder to the female subject; and (g) determining if the female sexual arousal disorder or female orgasmic disorder has been affected as a result of administration of the compound.